INDIGENOUS PHARMACEUTICALS
LOK SABHA
The Annual Special
301 Report for 2003, released by the United States Trade Representative
(USTR) retains India in the "Priority Watch List" alongwith
10 other countries. India is being kept under this category since
1995. USTR lists countries as "priority Foreign Country",
"Priority Watch List" and "Watch List". Under
US Rules, the USTR is obliged to initiate action against only
such countries as are listed under "Priority Foreign Country"
and that too only after holding consultations with the Governments
of the concerned countries. As such, there is no immediate threat
to the Indian Pharmaceutical Industry.
This information
was given by the Minister of State for Chemicals & Fertilizers,
Dr. Chhattra Pal Singh, in a written reply to a question in the
Lok Sabha today.
